BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 23442344)

  • 1. Socioeconomic status as a predictor of melanoma survival in a series of 1083 cases from Brazil: just a marker of health services accessibility?
    Quintella Mendes GL; Koifman S
    Melanoma Res; 2013 Jun; 23(3):199-205. PubMed ID: 23442344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden.
    Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Wagenius G; Carstensen J; Hansson J
    Eur J Cancer; 2013 Aug; 49(12):2705-16. PubMed ID: 23583439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
    Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
    McKenna DB; Lee RJ; Prescott RJ; Doherty VR
    Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological features and prognostic factors of cutaneous head and neck melanoma: a population-based study.
    Golger A; Young DS; Ghazarian D; Neligan PC
    Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):442-7. PubMed ID: 17515502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining the pathways linking lower socioeconomic status and advanced melanoma.
    Pollitt RA; Swetter SM; Johnson TM; Patil P; Geller AC
    Cancer; 2012 Aug; 118(16):4004-13. PubMed ID: 22179775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in survival of cutaneous melanoma are age dependent: an analysis of 7338 patients.
    Mervic L; Leiter U; Meier F; Eigentler T; Forschner A; Metzler G; Bartenjev I; Büttner P; Garbe C
    Melanoma Res; 2011 Jun; 21(3):244-52. PubMed ID: 21540649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment.
    Zell JA; Cinar P; Mobasher M; Ziogas A; Meyskens FL; Anton-Culver H
    J Clin Oncol; 2008 Jan; 26(1):66-75. PubMed ID: 18165642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Socioeconomic status and survival in older patients with melanoma.
    Reyes-Ortiz CA; Goodwin JS; Freeman JL; Kuo YF
    J Am Geriatr Soc; 2006 Nov; 54(11):1758-64. PubMed ID: 17087705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Previous pregnancy is a favourable prognostic factor in women with localised cutaneous melanoma.
    Vihinen P; Vainio-Kaila M; Talve L; Koskivuo I; Syrjänen K; Pyrhönen S
    Acta Oncol; 2012 May; 51(5):662-8. PubMed ID: 22486294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of socioeconomic status and district of residence on cutaneous malignant melanoma prognosis: a survival study on incident cases between 1991 and 2011 in the province of Ferrara, northern Italy.
    Borghi A; Corazza M; Virgili A; Lambertini AG; Caranci N; Pacelli B; Carcoforo P; Ferretti S
    Melanoma Res; 2017 Dec; 27(6):619-624. PubMed ID: 28723726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
    Schmidt H; Suciu S; Punt CJ; Gore M; Kruit W; Patel P; Lienard D; von der Maase H; Eggermont AM; Keilholz U; ;
    J Clin Oncol; 2007 Apr; 25(12):1562-9. PubMed ID: 17443000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced survival in patients with multiple primary melanoma.
    Doubrovsky A; Menzies SW
    Arch Dermatol; 2003 Aug; 139(8):1013-8. PubMed ID: 12925389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Later stage at diagnosis and worse survival in cutaneous malignant melanoma among men living alone: a nationwide population-based study from Sweden.
    Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Carstensen J; Hansson J
    J Clin Oncol; 2014 May; 32(13):1356-64. PubMed ID: 24687828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age is an independent poor prognostic factor in cutaneous head and neck melanoma.
    Stokes WA; Lentsch EJ
    Laryngoscope; 2014 Feb; 124(2):462-5. PubMed ID: 23881555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Number of primary melanomas is an independent predictor of survival in patients with metastatic melanoma.
    Murali R; Brown PT; Kefford RF; Scolyer RA; Thompson JF; Atkins MB; Long GV
    Cancer; 2012 Sep; 118(18):4519-29. PubMed ID: 22736239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Survival analysis in patients with cutaneous malignant melanoma].
    Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
    Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single-institution validation of the AJCC staging system for stage IV melanoma.
    Neuman HB; Patel A; Ishill N; Hanlon C; Brady MS; Halpern AC; Houghton A; Coit DG
    Ann Surg Oncol; 2008 Jul; 15(7):2034-41. PubMed ID: 18465172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcopenia as a prognostic factor among patients with stage III melanoma.
    Sabel MS; Lee J; Cai S; Englesbe MJ; Holcombe S; Wang S
    Ann Surg Oncol; 2011 Dec; 18(13):3579-85. PubMed ID: 21822551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.